申请人:Thomas Jefferson University
公开号:US11365174B2
公开(公告)日:2022-06-21
An effective therapeutic agent for the M2 channel comprising sulfonylamide or oxabicyclo structures effective for treating amantadine-resistant influenza A infections, and methods of treating amantadine-resistant influenza A infections through administration of the same.
一种由磺酰胺或氧杂双环结构组成的 M2 通道有效治疗剂,可有效治疗金刚烷胺抗性甲型流感感染,以及通过服用该治疗剂治疗金刚烷胺抗性甲型流感感染的方法。